2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Castration Resistant Prostate Cancer
1
Interventions
pembrolizumab
1270
Specimen Handling
921
Magnetic Resonance Spectroscopy
832
Carboplatin
829
Cyclophosphamide
802
Cisplatin
726
Nivolumab
682
Paclitaxel
639
Radiotherapy
613
Gemcitabine
578
Biopsy
556
Bevacizumab
477
Dexamethasone
445
fludarabine
405
Docetaxel
382
venetoclax
372
Oxaliplatin
365
Capecitabine
360
Fluorouracil
358
atezolizumab
345
durvalumab
338
Rituximab
336
Drug Therapy
330
Doxorubicin
319
Radiosurgery
316
Blood Specimen Collection
313
Pemetrexed
308
Standard of Care
306
Ipilimumab
305
Radiation
285
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Injections, Intramuscular
×
1 year
×
Clear all
NCT07161778
2025-09-09
TRICREST
Barts & The London NHS Trust
Phase 2
Completed
55 enrolled